ARA-290 acute-use positioning

Anti-inflammatory

Acute pain/inflammation modulation

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: Innate repair receptor activity
Primary market use: Neuropathy

Pharmacology

Molecular weight (Da): ~1258
Oral bioavailability: N/A
Half-life: ~2 min
Route tags: Route-dependent / verify
Evidence level: Human clinical
Clinical status: Investigational
Value-for-money score: 4 / 10

Reported protocol signal

Treatment length: 4-5 weeks SQ: • 1-5 mg daily (Muscle + Brawn)

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Listed separately only when used as symptom-modulator

Sources

https://clinicaltrials.gov/